New dystonic syndrome associated with butyrophenone therapy

Z Neurol. 1972;202(2):94-103. doi: 10.1007/BF00316159.
No abstract available

MeSH terms

  • Amines
  • Antiparkinson Agents / therapeutic use
  • Basal Ganglia / drug effects
  • Butyrophenones / adverse effects*
  • Butyrophenones / therapeutic use
  • Dementia / drug therapy
  • Female
  • Gait
  • Haloperidol / adverse effects*
  • Haloperidol / therapeutic use
  • Humans
  • Middle Aged
  • Movement Disorders / chemically induced*
  • Movement Disorders / drug therapy
  • Phenothiazines / adverse effects
  • Piperidines / adverse effects
  • Piperidines / therapeutic use
  • Posture

Substances

  • Amines
  • Antiparkinson Agents
  • Butyrophenones
  • Phenothiazines
  • Piperidines
  • Haloperidol